Evidence map›Paper›PMID 34991654›Full record

ArticleItalian journal of pediatrics2022

Prevalence of COVID-19 in children affected by allergic rhinoconjunctivitis and asthma: results from the second "SIAIP rhinosinusitis and conjunctivitis committee" survey.

Giulia Brindisi, Anna Maria Zicari, Giuseppe Fabio Parisi, Lucia Diaferio, Cristiana Indolfi, Giuseppe Marchese, Daniele Giovanni Ghiglioni, Giuseppina Rosaria Umano, Angela Klain, Gian Luigi Marseglia and 1 more

Open access · goldAbstract read
In one paragraph

Article in Italian journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Year 2022: exploring COVID-19 pandemic in children.Italian journal of pediatrics · 2023
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Giulia Brindisi *Department of Maternal Infantile and Urological Sciences, Division of Pediatric Allergology and Immunology, Sapienza University of Rome, 00185, Rome, Italy. giulia.brindisi@uniroma1.it.ORCID http://orcid.org/0000-0001-5059-6082
Anna Maria Zicari *Department of Maternal Infantile and Urological Sciences, Division of Pediatric Allergology and Immunology, Sapienza University of Rome, 00185, Rome, Italy.
Giuseppe Fabio ParisiDepartment of Clinical and Experimental Medicine, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy.
Lucia DiaferioDepartment of Pediatrics, Giovanni XXIII Hospital, University of Bari, 70126, Bari, Italy.
Cristiana IndolfiDepartment of Woman, Child and Specialized Surgery, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 2, 80138, Naples, Italy.
Giuseppe MarchesePrimary care pediatrician, Cedegolo, Brescia, Italy.
Daniele Giovanni GhiglioniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Via Francesco Sforza, 28, 20122, Milan, Italy.
Giuseppina Rosaria UmanoDepartment of Woman, Child and Specialized Surgery, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 2, 80138, Naples, Italy.
Angela KlainDepartment of Woman, Child and Specialized Surgery, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 2, 80138, Naples, Italy.
Gian Luigi MarsegliaDepartment of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of Pavia, Viale Camillo Golgi 19, 27100, Pavia, Italy.
Michele Miraglia Del GiudiceDepartment of Woman, Child and Specialized Surgery, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 2, 80138, Naples, Italy.
University of Campania "Luigi Vanvitelli" · ITSapienza University of Rome · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITOspedale Pediatrico Giovanni XXIII · ITUniversity of Catania · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of allergic sensitization seems to be protective against SARS CoV2 infection. The aim of this study was to evaluate, using online surveys, the impact of COVID-19 on Italian allergic children, comparing the prevalence of AR and asthma symptoms between the first and second pandemic wave.

methodsBoth surveys were emailed to Italian pediatricians in April 2020 (first survey) and in March 2021 (second survey). The first one was related to the impact of COVID-19 and the most frequently reported symptoms. The second one was superimposed on the previous one, taking into account some additional aspects in the management of disease.

resultsA total of 99 pediatricians participated in the first survey and 267 in the second one. The first survey showed that, asthma and allergic rhinoconjunctivitis prevalence was mostly between 0 and 20% throughout the country. The second survey showed a lower prevalence of both diseases nationwide in comparison to the first one. Comparing the two surveys, statistically significant differences were reported only in the distribution of asthma prevalence in Southern Italy while no differences were highlighted in the North and in the Center. Finally regarding allergic rhinoconjunctivitis prevalence, no differences were noticed nationwide.

conclusionsAllergic rhinoconjunctivitis and asthma, if under control, did not represent risk factors for the susceptibility to SARS CoV2. Therefore, it is strongly recommended to continue therapies during COVID-19 outbreak, according to the international guidelines. However, being COVID-19 a new disease, actual knowledge will undergo continuous improvements over time.

Indexed as

AsthmaChildConjunctivitis, AllergicCOVID-19HumansItalyPrevalenceRhinitis, AllergicRisk FactorsSurveys and QuestionnairesAllergic rhinoconjunctivitisAsthmaChildrenCOVID - 19Online-surveySARS CoV2

Identifiers

PMID34991654
PMCPMC8733922
OpenAlexW4205113644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.